MAUDE Adverse Event Report: BIO-RAD LABORATORIES, INC. LIQUICHEK IMMUNOASSAY PLUS CONTROL, TRILEVEL; MUITI-ANALYTE CONTROLS, ALL KINDS (ASSAYED)

Model Number	360
Medical Device Problem Code	Human-Device Interface Problem (2949)
Health Effect - Clinical Code	No Consequences Or Impact To Patient (2199)
Date of Event	03/04/2020
Type of Reportable Event	Malfunction
Additional Manufacturer Narrative
Instruction for use (ifu) provided by bio-rad for testing liquichek immunoassay plus control, liquichek cardiac markers plus control lt, and liquid assayed multiqual indicated products contain human source materials and should be considered potentially infectious and handled with the same precautions used with patient specimens in accordance with good laboratory practice.Each human donor unit used to manufacture this product was tested as required by fda accepted methods.Tests results were non-reactive or negative for evidence of infection due to human immunodeficiency virus (hiv), hepatitis b virus (hbv) and hepatitis c virus (hcv).This product may also contain other human source materials for which there are no approved tests.In accordance with good laboratory practice, all human source material should be considered potentially infectious and handled with the same precautions used with patient specimens.Liquichek immunoassay plus control has a hazardous warning contain sodium azide as a preservative.Sodium azide can react with copper, brass, lead, and solder in piping systems to form explosive compounds of lead azide and copper azide.
Event or Problem Description
On (b)(6) 2020, a laboratory information manager from (b)(6) medical center- (b)(6) called bio-rad qsd technical support to report a potential adverse event that occurred with a technician at their facility.In the facility chemistry lab, the employee removed qc rack from instrument and emptied a rack of qc vials into sink.While dumping, the mixture of qc splashed into the technician's eyes.The technician was not wearing safety glasses, which is a laboratory requirement for ppe in this facility.The following qc products were on the qc rack and plashed in the technician's eyes: liquichek immunoassay plus control: trilevel: lot 41000.Liquichek cardiac markers plus control lt: level 2: lot 23692, level 3: lot 23693, level 1b: lot 23695.Liquid assayed multiqual: level 1: lot 45791, level 3: lot 45793.The employee washed eyes immediately in the emergency eye wash station.The incident was reported to facilities health and the employee was sent to the employee health center for evaluation.No details of the visit to employee health center was provided.It was reported that no additional medical attention was required.The employee and facility was provided with package insert, sds and certificate of analysis for all 8 products that were splashed in the technician's eyes.

• Brand Name: LIQUICHEK IMMUNOASSAY PLUS CONTROL, TRILEVEL
• Common Device Name: MUITI-ANALYTE CONTROLS, ALL KINDS (ASSAYED)
• Manufacturer (Section D): BIO-RAD LABORATORIES, INC.; 9500 jeronimo road; irvine, ca
• MDR Report Key: 9806089
• Report Number: 2016706-2020-00002
• Device Sequence Number: 10957099
• Product Code: JJY
• UDI-Device Identifier: 00847661001119
• UDI-Public: 00847661001119
• Combination Product (Y/N): N
• Initial Reporter Country: US
• PMA/510(K) Number: K001373
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Reporter Type: Manufacturer
• Report Source: health professional,user faci
• Initial Reporter Occupation: Other Health Care Professional
• Type of Report: Initial
• Report Date (Section B): 03/09/2020

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Operator of Device: Other
• Device Expiration Date: 02/28/2021
• Device Model Number: 360
• Device Catalogue Number: 360
• Device Lot Number: 41000
• Was Device Available for Evaluation?: No
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 03/04/2020
• Initial Report FDA Received Date: 03/09/2020
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Other